|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
103,650,000 |
Market
Cap: |
1.62(B) |
Last
Volume: |
789,519 |
Avg
Vol: |
1,671,490 |
52
Week Range: |
$11.62 - $17.29 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drugs - Generic |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 604 |
Guru Rank Value : 3 |
Guru Occurances : 1 |
|
|
|
|
|
|
|
Company Profile Catalyst Pharmaceuticals is a biopharmaceutical company focused on in-licensing, developing and commercializing medicines for patients living with rare diseases. Co.'s primary product, Firdapse®, is used for the treatment of adult patients (ages 17 and above) with Lambert-Eaton, Myasthenic Syndrome, a rare autoimmune neuromuscular disorder characterized by muscle weakness of the limbs. Co. has developed its vigabatrin (CPP-109) as a generic version of Sabril®. Co. has an agreement with Endo International plc's subsidiary, Endo Ventures Limited, for the development and commercialization of generic Sabril® tablets through Endo's U.S. Generic Pharmaceuticals segment, Par Pharmaceutical.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
152,656 |
276,656 |
406,656 |
4,306,172 |
Total Sell Value |
$2,459,484 |
$4,152,934 |
$5,994,534 |
$64,305,632 |
Total People Sold |
5 |
6 |
7 |
13 |
Total Sell Transactions |
5 |
8 |
11 |
55 |
End Date |
2024-03-12 |
2023-12-10 |
2023-06-11 |
2022-06-11 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Mcenany Patrick J |
President and CEO |
|
2010-06-15 |
4 |
B |
$1.04 |
$9,733 |
D/D |
9,359 |
3,125,430 |
3.15 |
- |
|
O'keeffe Charles B |
Director |
|
2010-03-18 |
4 |
B |
$0.72 |
$3,605 |
D/D |
5,000 |
78,876 |
2.31 |
- |
|
Wallace Milton J |
Director |
|
2010-03-04 |
4 |
B |
$0.69 |
$15,525 |
D/D |
22,500 |
373,900 |
2.39 |
- |
|
Wallace Milton J |
Director |
|
2010-03-03 |
4 |
B |
$0.67 |
$938 |
D/D |
1,400 |
351,400 |
2.31 |
- |
|
Coelho Philip H |
Director |
|
2010-02-26 |
4/A |
B |
$0.67 |
$5,360 |
D/D |
8,000 |
299,182 |
2.39 |
- |
|
Coelho Philip H |
Director |
|
2010-02-26 |
4 |
B |
$0.67 |
$3,719 |
D/D |
5,550 |
296,732 |
2.31 |
- |
|
Grande Alicia |
Controller & CAO |
|
2009-11-19 |
4 |
B |
$0.65 |
$2,730 |
D/D |
4,200 |
24,046 |
2.66 |
- |
|
Grande Alicia |
Controller & CAO |
|
2009-11-18 |
4 |
B |
$0.65 |
$3,250 |
D/D |
5,000 |
19,846 |
2.66 |
- |
|
Wallace Milton J |
Director |
|
2009-11-18 |
4 |
B |
$0.68 |
$17,037 |
D/D |
25,054 |
350,000 |
2.39 |
- |
|
Wallace Milton J |
Director |
|
2009-11-17 |
4 |
B |
$0.73 |
$14,488 |
D/D |
19,846 |
324,946 |
2.39 |
- |
|
O'keeffe Charles B |
Director |
|
2009-11-17 |
4 |
B |
$0.73 |
$7,300 |
D/D |
10,000 |
73,876 |
2.39 |
- |
|
Coelho Philip H |
Director |
|
2009-11-17 |
4 |
B |
$0.73 |
$7,300 |
D/D |
10,000 |
291,182 |
2.39 |
- |
|
Mcenany Patrick J |
President and CEO |
|
2009-11-16 |
4 |
B |
$0.75 |
$18,750 |
D/D |
25,000 |
3,116,071 |
3.15 |
- |
|
Coelho Philip H |
Director |
|
2009-11-16 |
4 |
B |
$0.75 |
$7,550 |
D/D |
10,000 |
281,182 |
2.39 |
- |
|
Coelho Philip H |
Director |
|
2009-11-13 |
4 |
B |
$0.79 |
$7,900 |
D/D |
10,000 |
271,182 |
2.39 |
- |
|
Wallace Milton J |
Director |
|
2009-05-22 |
4 |
B |
$2.06 |
$206 |
D/D |
100 |
305,100 |
2.31 |
- |
|
Tierney David S |
Director |
|
2009-03-06 |
4 |
B |
$1.55 |
$4,650 |
D/D |
3,000 |
185,402 |
2.31 |
- |
|
Mcenany Patrick J |
President and CEO |
|
2009-03-06 |
4 |
B |
$1.55 |
$7,750 |
D/D |
5,000 |
3,091,071 |
3.15 |
- |
|
Weinstein Jack |
V.P., Treasurer & CFO |
|
2009-03-06 |
4 |
B |
$1.55 |
$2,170 |
D/D |
1,400 |
11,993 |
2.66 |
- |
|
Winship M Douglas |
V.P. of Regulatory Operations |
|
2009-03-06 |
4 |
B |
$1.55 |
$4,650 |
D/D |
3,000 |
4,794 |
2.66 |
- |
|
Mcenany Patrick J |
President and CEO |
|
2008-12-30 |
4 |
B |
$1.69 |
$2,395 |
D/D |
1,417 |
3,086,071 |
3.15 |
- |
|
Coelho Philip H |
Director |
|
2008-12-23 |
4 |
B |
$1.60 |
$1,600 |
D/D |
1,000 |
261,182 |
2.31 |
- |
|
Huckel Hubert E Md |
Director |
|
2008-12-19 |
4 |
B |
$1.50 |
$4,655 |
I/I |
3,003 |
1,179,134 |
2.17 |
- |
|
Huckel Hubert E Md |
Director |
|
2008-12-18 |
4 |
B |
$1.99 |
$3,974 |
I/I |
1,997 |
1,176,131 |
2.17 |
- |
|
Weinstein Jack |
V.P., Treasurer & CFO |
|
2008-12-18 |
4 |
B |
$2.24 |
$224 |
D/D |
100 |
10,593 |
2.66 |
- |
|
439 Records found
|
|
Page 15 of 18 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|